The study found that MS patients had 50% less amyloid plaque accumulation, a key indicator of Alzheimer’s, compared to non-MS individuals. This connection between MS and reduced Alzheimer’s risk highlights potential immune-related mechanisms that may be leveraged for therapeutic strategies.

Key Facts:

• MS patients are 50% less likely to develop amyloid plaques, a hallmark of Alzheimer’s.
• The immune response in MS might help reduce amyloid buildup in the brain.
• This discovery opens up new avenues for Alzheimer’s research and potential treatments.